Companies / RAPT Therapeutics, Inc.
RAPT Therapeutics, Inc.
RAPTCIK 1673772SOUTH SAN FRANCISCO, CA
Financials · FY2023
Ownership
27.7M shares outstanding · as of Nov 3, 2025
Ownership
| 10%+ / strategic | 5.76% | 1,596,542 |
| Institutions | 10.83% | 3,002,436 |
| Public float | 83.40% | 23,111,893 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 9
View all →| Insider | % of shares | Shares |
|---|---|---|
Braunstein ScottDirector | 0.00% | 0 |
Brockstedt Dirk G.CHIEF SCIENTIFIC OFFICER | 0.00% | 0 |
Dombkowski Ashley L.Director | 0.00% | 0 |
Giordano Michael FDirector | 0.00% | 0 |
Gray Mary AnnDirector | 0.00% | 0 |
Kozick LindaDirector | 0.00% | 0 |
Lyons-Williams LoriDirector | 0.00% | 0 |
Wong Brian RussellCEOPRESIDENT AND CEO · Director | 0.00% | 0 |
Young Rodney KBCHIEF FINANCIAL OFFICER | 0.00% | 0 |
Institutional holders 4
View all →| Holder | Value | % of shares |
|---|---|---|
| $94.63M | 10.08% | |
| $5.29M | 0.56% | |
| $421.2K | 0.04% | |
| $79.9K | 0.14% |
Activity
Dec 31, 2025View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q4 2023 as of | Barclays PLC 13F manager | Add | Common stock | $616.8K | +25K +46.27% | 78,473 0.28% of shares | low |
| Q1 2023 as of | Barclays PLC 13F manager | Trim | Common stock | $-543.5K | -30K -37.18% | 50,034 0.18% of shares | low |
| Q2 2023 as of | Barclays PLC 13F manager | Add | Common stock | $269.3K | +14K +28.78% | 64,436 0.23% of shares | low |
| Q2 2024 as of | Barclays PLC 13F manager | Trim | Common stock | $-250.4K | -82K -88.63% | 10,534 0.04% of shares | low |
| Q3 2023 as of | Barclays PLC 13F manager | Trim | Common stock | $-179.2K | -11K -16.74% | 53,651 0.19% of shares | low |
| Q1 2024 as of | Barclays PLC 13F manager | Add | Common stock | $127.0K | +14K +18.02% | 92,617 0.33% of shares | low |
| Q3 2024 as of | Barclays PLC 13F manager | Add | Common stock | $58.7K | +29K +277.15% | 39,729 0.14% of shares | low |
| Q2 2025 as of | Barclays PLC 13F manager | Exit | Common stock | $-42.7K | -35K -100.00% | 0 | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Glazer Capital, LLC | Passive13G | — |
| RTW Investments, LP | Passive13G/A | — |
| Deep Track Capital, LP | Passive13G/A | — |
| Orbimed Advisors LLC | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| RAPT | — | 75382E109 |